TRADE NEWS: Agilent Technologies Introduces Dissolution Apparatus for Pharmaceutical Quality Control
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE:A) today introduced the 708-DS Dissolution Apparatus, a quality control instrument that can be configured for manual and ...
Improved Pharma, a leader in pharmaceutical research and solid-state chemistry, is pleased to announce a significant upgrade to its analytical capabilities with the installation of a fully automated ...
Agilent Technologies Inc. has introduced the Cary 8454 UV Dissolution System, which incorporates new Cary 8454 UV-Vis Spectrophotometer technology and enables researchers to sample the entire UV ...
Agilent Technologies Inc. has introduced the 280-DS Mechanical Qualification System, a new instrument for routine and effortless calibration of a dissolution apparatus. The 280-DS accurately measures, ...
Dissolution testing is experiencing a refresh thanks to a variety of market drivers. Dissolution testing is an integral part of pharmaceutical development, providing drug companies with the analytical ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the introduction of the NanoDis System for nanoparticle dissolution testing. Combining Agilent instrumentation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results